Together with the fact that K-Ras mutations were rare in CML (circa 5% of CML), the findings suggested that this pathway was not responsible for the decreasing Nrf2 transcription by Wogonin. Here, KRAS is linked to chronic myelogenous leukemia, BCR-ABL1 positive.